Cosmetics

New customs measures taking effect in December 2026 will reshape how cosmetics are inspected, cleared, labeled, and electronically verified in China.

China’s NMPA released a AI roadmap for smarter supervision across drugs, medical devices, and cosmetics regulation, covering AI-supported review, inspections, traceability, risk monitoring, and digital governance through 2035.

China’s NIFDC releases 6 new technical guidelines for high-risk cosmetics, impacting hair dye, perming, and sunscreen product compliance.

Hong Kong classifies classifcation of injectable products, impacting medical aesthetics and borderline products.

TFDA eliminates legacy cosmetics review fees, reducing compliance costs for foreign companies.

Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.

China’s NMPA has opened consultation on a draft mandatory toothpaste safety standard that could tighten product requirements.

China NMPA adds four new cosmetic testing methods effective July 2026, impacting compliance and safety assessment strategies.

China’s NMPA updates cosmetics testing methods, adding CBD detection and tighter impurity controls impacting global compliance.

Indonesia’s BPOM has strengthened clinical trial approval procedures and introduced detailed requirements for cosmetic clinical trials.

Vietnam’s MoH recently published Circular drops several healthcare advertising regulations and streamlines requirements for many categories.

Vietnam’s draft cosmetic management decree would replace existing rules and strengthen post-market controls for cosmetic companies.